Briefcases -- XARELTO (rivaroxaban) MDL 2592 USDC ED Louisiana -- Evidentiary and Research Documents -- Media References

Documents: Media References

File Name Posted
Johnson & Johnson et al Corrupt Terror Acts Complaint (Iraq) USDC SD NY October 17, 2017 August 29, 2019
Xarelto MDL 2592 MTN NEWS ALERT_Johnson & Johnson Xeralto Trial Facing $2.5 Billion in Liability (April 7, 2017) October 29, 2018
Xarelto Litigation Potential Plaintiff Numerosity Estimate October 24, 2015
Anticoagulants.mp4 November 23, 2015
Atrial Fibrillation Epidemiology _ Novel Oral Anticoagulants - Samuel Goldhaber, MD.mp4 November 23, 2015
coagulation cascade and warfarin interaction with vitamin K.mp4 November 23, 2015
Coagulation Cascade Animation - Physiology of Hemostasis.mp4 November 23, 2015
Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE).mp4 November 23, 2015
FDA Approves Rivaroxaban.mp4 November 23, 2015
How to Pronounce Rivaroxaban.mp4 November 23, 2015
New Anticoagulants Trials and Tribulations.mp4 November 23, 2015
Newer Anticoagulants in Atrial Fibrillation Should I Incorporate Them Into Clinical Practice.mp4 November 23, 2015
Novel Anticoagulants Jeffrey I. Weitz, MD Part 1 of 2.mp4 November 23, 2015
ROCKET AF, EMPHASIS-HF, and DEFINE AHA 2010 Overview from Chicago.mp4 November 23, 2015
The New Anticoagulants in Cardiovascular Disease Atrial Fibrillation and Beyond.mp4 November 23, 2015
Quarter watch.pdf November 23, 2015
Quarter Watch 2011.pdf November 23, 2015
XareltoMedGuide.docx November 23, 2015
Xarelto has Higher Rate of Bleeding.pdf November 23, 2015
Xarelto Bleeding.pdf November 23, 2015
Xarelto Causes More Bleeding.docx November 23, 2015
LID Xarelto vs Eliguis.docx November 23, 2015
Xarelto Pharmacokentics and Pharmacodynamics.docx November 23, 2015
NEJM Acute Coronary Syndrome.pdf November 23, 2015
NEJM Acute Limb Ischemia.pdf November 23, 2015
NEJM Acute Pulmonary Embolism.pdf November 23, 2015
NEJM Apixaban vs Enoxaparin (2).pdf November 23, 2015
NEJM Apixaban vs Enoxaparin.pdf November 23, 2015
NEJM Asprin for VT and AT.pdf November 23, 2015
NEJM Extended Treatment of VT.pdf November 23, 2015
NEJM New Anticoagulants.pdf November 23, 2015
NEJM Prevention of Ischemic Stroke.pdf November 23, 2015
NEJM Reversal Agent.pdf November 23, 2015
NEJM Rivaroxaban vs Enoxaparin.pdf November 23, 2015
NEJM Therapeutic Potential of Factor Xa Inhibitors.pdf November 23, 2015
NEJM Xarelto for P.E..pdf November 23, 2015
NEJM Xarelto for Thrombo in Acutely Ill.pdf November 23, 2015
NEJM Xarelto for Thromboprophalazis.pdf November 23, 2015
NEJM Xarelto vs Warfarin.pdf November 23, 2015
Xarelto Post Market Study Defendant.pdf November 23, 2015
Pharmacodynamic and Pharmacokentics of Xarelto.pdf November 23, 2015
Rocket AF Study.pdf December 21, 2015